cinobufotalin has been researched along with Cancer of Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WF; Deng, ST; Deng, YL; Fang, WY; Hou, RT; Hu, Z; Li, YH; Liu, JH; Liu, X; Liu, Z; Su, Y; Wang, YB; Wu, LY; Xian, RT; Xie, YY; Xu, P; Yan, WW; Yang, HL; Zhu, ZB | 1 |
| Chen, P; Chen, X; Deng, C; Du, S; Guo, T; Huang, J; Lu, M | 1 |
| Xu, T; Yin, Y; Zhang, F | 1 |
| Hui, PP; Kai, S; Lu, JH; Zhao, H | 1 |
1 review(s) available for cinobufotalin and Cancer of Lung
| Article | Year |
|---|---|
Cinobufotalin injection combined with chemotherapy for the treatment of advanced NSCLC in China: A PRISMA-compliant meta-analysis of 29 randomized controlled trials.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bufanolides; Carcinoma, Non-Small-Cell Lung; China; Drugs, Chinese Herbal; Female; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Quality of Life; Randomized Controlled Trials as Topic; Survival Analysis | 2019 |
3 other study(ies) available for cinobufotalin and Cancer of Lung
| Article | Year |
|---|---|
The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma of Lung; Antineoplastic Agents; beta Catenin; Bufanolides; Calmodulin-Binding Proteins; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Myosin Heavy Chains; Myosins; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Transcription Factors; Ubiquitin-Specific Peptidase 7 | 2022 |
Cinobufotalin Induces Ferroptosis to Suppress Lung Cancer Cell Growth by lncRNA LINC00597/hsa-miR-367-3p/TFRC Pathway via Resibufogenin.
Topics: Cell Proliferation; Ferroptosis; Humans; Lung Neoplasms; MicroRNAs; Receptors, Transferrin; RNA, Long Noncoding | 2023 |
Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bufanolides; Cell Death; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Lactones; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering; Spiro Compounds; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |